✦ LIBER ✦

CH1: COST-EFFECTIVENESS ANALYSIS OF IRINOTECAN AS FIRST-LINE THERAPY IN ADVANCED COLORECTAL CANCER

✍ Scribed by C Schmitt; C Levy-Piedbois; M Frappe; I Durand-Zaleski

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness analysis of irinoteca

✍ A. Bearne; A. Burrell 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 345 KB

Cost-effectiveness analysis of irinoteca

✍ Warren Mark Hart; Carlos Rubio-Terrés; Linda Pronk; Svetlana Kobina; Eduardo Día 📂 Article 📅 2003 🏛 Springer Milan 🌐 Spanish ⚖ 188 KB

PCA6: COST-EFFECTIVENESS OF GEMCITABINE

✍ S Trippoli; A Messori 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

High-dose, single-agent irinotecan as fi

✍ M. Ychou; J. Raoul; F. Desseigne; C. Borel; F. Caroli-Bosc; J. Jacob; J. Seitz; 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 279 KB

Cost-effectiveness of anastrozole versus

✍ W.Robert Simons; David Jones; Aman Buzdar 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 175 KB

PCN5: FIRST-LINE THERAPY FOR ADVANCED BR

✍ M Marchetti; N Liberato; G Barosi 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB